Antithrombotic treatment in patients with stable CAD and AF - 5-year follow-up data from the CLARIFY registry

Application of DAPT score to predict ischaemic and bleeding events in patients who underwent drug-eluting stent implantation: a landmark analysis of large pooled cohort

Growth differentiation factor 15 and bleeding risk with ticagrelor in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.

In-hospital switch of P2Y12 drugs in patients presenting with acute coronary syndrome: a meta-analysis of 14 observational and randomized studies including 10961 patients.

Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: OLTAT registry

The effect of CYP2C19 gene polymorphism and clopidogrel dose on clinical outcomes in Asian populations with CAD receiving antiplatelet therapy.

Greater pharmacodynamic efficacy of ticagrelor compared to clopidogrel in patients with diabetes mellitus and stable coronary artery disease: a randomized investigation

Twice daily half-dosage aspirin intake promotes equal and perhaps even more platelet inhibition when compared to standard practice of once daily

Glycemic variability assessed by continuous glucose monitoring and antiplatelet responsiveness in patients undergoing coronary stenting: results from the observational GLYVAR study

Positive effect of new oral anticoagulation on coronary plaque composition? A coronary CT study